Sana Biotechnology, INC Form 4 insider transactions

Sana Biotechnology's CEO, Steve Harr, acquired 900,000 stock options and 200,000 restricted stock units on March 7, 2024, according to a Form 4 filing.

Christian Hordo, EVP and Chief Business Officer of Sana Biotechnology, reports the acquisition of stock options and restricted stock units.

Nathan Hardy, EVP and CFO of Sana Biotechnology, reports acquisition of stock options and restricted stock units.

Bernard J. Cassidy, EVP & General Counsel of Sana Biotechnology, reports the acquisition of stock options and restricted stock units.